Patents by Inventor Julia Amadio
Julia Amadio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11865179Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: GrantFiled: June 15, 2021Date of Patent: January 9, 2024Assignee: TherapeuticsMD, Inc.Inventors: Janice Cacace, Peter H. R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick, Neda Irani
-
Publication number: 20230210765Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.Type: ApplicationFiled: October 12, 2022Publication date: July 6, 2023Applicant: TherapeuticsMD, Inc.Inventors: Brian A. BERNICK, Julia AMADIO, Peter H.R. PERSICANER
-
Publication number: 20230062295Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.Type: ApplicationFiled: March 28, 2022Publication date: March 2, 2023Applicant: TherapeuticsMD, Inc.Inventors: Brian A. BERNICK, Thorsteinn THORSTEINSSON, Peter H.R. PERSICANER, Janice Louise CACACE, Frederick D. SANCILIO, Neda IRANI, Julia AMADIO
-
Patent number: 11497709Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.Type: GrantFiled: March 30, 2020Date of Patent: November 15, 2022Assignee: TherapeuticsMD, Inc.Inventors: Brian A. Bernick, Julia Amadio, Peter H.R. Persicaner
-
Patent number: 11351182Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.Type: GrantFiled: March 27, 2020Date of Patent: June 7, 2022Assignee: TherapeuticsMD, Inc.Inventors: Brian A. Bernick, Thorsteinn Thorsteinsson, Peter H. R. Persicaner, Janice Louise Cacace, Frederick D. Sancilio, Neda Irani, Julia Amadio
-
Patent number: 11304959Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.Type: GrantFiled: January 17, 2020Date of Patent: April 19, 2022Assignee: TherapeuticsMD, Inc.Inventors: Brian A. Bernick, Thorsteinn Thorsteinsson, Peter H. R. Persicaner, Janice Louise Cacace, Frederick D. Sancilio, Neda Irani, Julia Amadio
-
Publication number: 20220040307Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: June 15, 2021Publication date: February 10, 2022Applicant: TherapeuticsMD, Inc.Inventors: Janice Cacace, Peter H.R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick, Neda IRANI
-
Patent number: 11241445Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.Type: GrantFiled: March 27, 2020Date of Patent: February 8, 2022Assignee: TherapeuticsMD, Inc.Inventors: Brian A. Bernick, Thorsteinn Thorsteinsson, Peter H. R. Persicaner, Janice Louise Cacace, Frederick D. Sancilio, Neda Irani, Julia Amadio
-
Patent number: 11033626Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: GrantFiled: September 20, 2019Date of Patent: June 15, 2021Assignee: TherapeuticsMD, Inc.Inventors: Janice Cacace, Peter H. R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick, Neda Irani
-
Publication number: 20200297735Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.Type: ApplicationFiled: March 27, 2020Publication date: September 24, 2020Applicant: TherapeuticsMD, Inc.Inventors: Brian A. BERNICK, Thorsteinn THORSTEINSSON, Peter H.R. PERSICANER, Janice Louise CACACE, Frederick D. SANCILIO, Neda IRANI, Julia AMADIO
-
Publication number: 20200297736Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.Type: ApplicationFiled: March 27, 2020Publication date: September 24, 2020Applicant: TherapeuticsMD, Inc.Inventors: Brian A. BERNICK, Thorsteinn THORSTEINSSON, Peter H.R. PERSICANER, Janice Louise CACACE, Frederick D. SANCILIO, Neda IRANI, Julia AMADIO
-
Publication number: 20200281849Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.Type: ApplicationFiled: March 30, 2020Publication date: September 10, 2020Applicant: TherapeuticsMD, Inc.Inventors: Brian A. BERNICK, Julia AMADIO, Peter H.R. PERSICANER
-
Publication number: 20200268888Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: September 20, 2019Publication date: August 27, 2020Applicant: TherapeuticsMD, Inc.Inventors: Janice Cacace, Peter H.R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick
-
Publication number: 20200147104Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.Type: ApplicationFiled: January 17, 2020Publication date: May 14, 2020Applicant: TherapeuticsMD, Inc.Inventors: Brian A. BERNICK, Thorsteinn THORSTEINSSON, Peter H.R. PERSICANER, Janice Louise CACACE, Frederick D. SANCILIO, Neda IRANI, Julia AMADIO
-
Patent number: 10537581Abstract: According to various embodiments of this disclosure, pharmaceutical compositions comprising solubilized estradiol are provided. In various embodiments, such compositions are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy.Type: GrantFiled: October 22, 2014Date of Patent: January 21, 2020Assignee: TherapeuticsMD, Inc.Inventors: Brian A. Bernick, Thorsteinn Thorsteinsson, Peter H. R. Persicaner, Janice Louise Cacace, Frederick D. Sancilio, Neda Irani, Julia Amadio
-
Publication number: 20190381068Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: February 12, 2019Publication date: December 19, 2019Applicant: TherapeuticsMD, Inc.Inventors: Julia AMADIO, Brian Bernick, Peter H.R. Persicaner
-
Patent number: 10471148Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: GrantFiled: March 9, 2017Date of Patent: November 12, 2019Assignee: TherapeuticsMD, Inc.Inventors: Janice Cacace, Peter H. R. Persicaner, Thorsteinn Thorsteinsson, Frederick Sancilio, Julia Amadio, Brian Bernick
-
Publication number: 20190070197Abstract: This disclosure relates to transdermal pharmaceutical compositions containing progesterone in combination with one or more solubilizing agents and penetration enhancers, wherein the pharmaceutical compositions are formulated as creams for topical administration. In some embodiments, the transdermal pharmaceutical compositions contain progesterone, a medium-chain oil, and d-limonene. In some embodiments, the transdermal pharmaceutical compositions contain progesterone, a medium-chain oil, a penetration enhancer (e.g., propylene glycol, a fatty acid ester of propylene glycol, a glycol ether), and optionally d-limonene. In certain embodiments, the pharmaceutical compositions further include estradiol. Methods for treating conditions associated with hormone deficiency in a subject are also described.Type: ApplicationFiled: September 7, 2018Publication date: March 7, 2019Inventors: JULIA AMADIO, ANNETTE SHADIACK, PETER H.R. PERSICANER, RICHARD WINNEKER, JASON LEGASSIE, THORSTEINN THORSTEINSSON, AJAY GHANTA
-
Patent number: 10098894Abstract: This disclosure relates to transdermal pharmaceutical compositions containing progesterone in combination with one or more solubilizing agents and penetration enhancers, wherein the pharmaceutical compositions are formulated as creams for topical administration. In some embodiments, the transdermal pharmaceutical compositions contain progesterone, a medium-chain oil, and d-limonene. In some embodiments, the transdermal pharmaceutical compositions contain progesterone, a medium-chain oil, a penetration enhancer (e.g., propylene glycol, a fatty acid ester of propylene glycol, a glycol ether), and optionally d-limonene. In certain embodiments, the pharmaceutical compositions further include estradiol. Methods for treating conditions associated with hormone deficiency in a subject are also described.Type: GrantFiled: July 29, 2015Date of Patent: October 16, 2018Assignee: TherapeuticsMD, Inc.Inventors: Julia Amadio, Annette Shadiack, Peter H. R. Persicaner, Richard Winneker, Jason Legassie, Thorsteinn Thorsteinsson, Ajay Ghanta
-
Publication number: 20180055855Abstract: This disclosure provides progesterone formulations, methods of using these formulations, and their related pharmacokinetic parameters. In particular embodiments, the formulations disclosed herein allow for a reduction in the amount of progesterone administered to a patient in need thereof, while still providing the benefits of a larger dosage amount.Type: ApplicationFiled: August 2, 2017Publication date: March 1, 2018Applicant: TherapeuticsMD, Inc.Inventors: Julia AMADIO, Brian BERNICK, Peter H.R. PERSICANER